Necroptosis in development, inflammation and disease

R Weinlich, A Oberst, HM Beere… - Nature reviews Molecular …, 2017 - nature.com
In the early 2000s, receptor-interacting serine/threonine protein kinase 1 (RIPK1), a
molecule already recognized as an important regulator of cell survival, inflammation and …

Regulated necrosis: the expanding network of non-apoptotic cell death pathways

TV Berghe, A Linkermann, S Jouan-Lanhouet… - … reviews Molecular cell …, 2014 - nature.com
Cell death research was revitalized by the understanding that necrosis can occur in a highly
regulated and genetically controlled manner. Although RIPK1 (receptor-interacting protein …

RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development

Y Bai, Y Qiao, M Li, W Yang, H Chen, Y Wu… - European Journal of …, 2024 - Elsevier
Within the field of medical science, there is a great deal of interest in investigating cell death
pathways in the hopes of discovering new drugs. Over the past two decades …

Necroptosis as an alternative form of programmed cell death

DE Christofferson, J Yuan - Current opinion in cell biology, 2010 - Elsevier
The family of death receptors plays a critical role in regulating cell number and eliminating
harmful or virally infected cells. Agonistic stimulation of death receptors is known to lead two …

Necroptosis: Pathway diversity and characteristics

MC de Almagro, D Vucic - Seminars in cell & developmental biology, 2015 - Elsevier
Regulated cell death is a physiological process that controls organismal homeostasis.
Deregulation of cell death can lead to the development of a number of human diseases and …

The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases

X Qin, L Hu, SN Shi, X Chen, C Zhuang… - Biochemical …, 2020 - Elsevier
Necroptosis is a form of programmed, caspase-independent cell death that is involved in
various pathologic disorders such as ischemia/reperfusion injury, acute kidney injury and …

[HTML][HTML] Combined knockout of RIPK3 and MLKL reveals unexpected outcome in tissue injury and inflammation

C Moerke, F Bleibaum, U Kunzendorf… - Frontiers in cell and …, 2019 - frontiersin.org
Necroptosis, initially identified as a backup cell death program when apoptosis is hindered,
is a prominent feature in the etiology and progression of many human diseases, such as …

Necroptosis

A Linkermann, DR Green - New England Journal of Medicine, 2014 - Mass Medical Soc
Necroptosis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

Pharmacological inhibition of necroptosis promotes human breast cancer cell proliferation and metastasis

F Shen, X Pan, M Li, Y Chen, Y Jiang… - OncoTargets and …, 2020 - Taylor & Francis
Background Breast cancer remains a great threat to females worldwide. As a recently
defined programmed cell death pathway that associates with immune activation …

Mediators of necroptosis: from cell death to metabolic regulation

X Wu, LE Nagy, J Gautheron - EMBO molecular medicine, 2024 - embopress.org
Necroptosis, a programmed cell death mechanism distinct from apoptosis, has garnered
attention for its role in various pathological conditions. While initially recognized for its …